Table 53Vildagliptin versus pioglitazone: male, BMI 30

Male BMI 30No complicationsWith complications
VildagliptinPioglitazoneNetVildagliptinPioglitazoneNet
UKPDS QALYs8.5618.590−0.0298.3538.378−0.025
Total QALYs8.4688.479−0.0118.2628.269−0.007
Direct Drug Cost£5,371£5,824−£453£5,220£5,665−£445
Total Cost£15,731£16,180−£449£16,309£16,756−£446
ICER£39,846£66,799

From: 8, Cost effectiveness modelling of the new drugs

Cover of Newer Agents for Blood Glucose Control in Type 2 Diabetes (Supplement)
Newer Agents for Blood Glucose Control in Type 2 Diabetes (Supplement) [Internet].
NICE Clinical Guidelines, No. 87S.
Waugh N, Cummins E, Royle P, et al.
Copyright © 2009, National Institute for Health and Clinical Excellence.

All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.